Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), an innovative cancer drug discovery and development company, is focused on discovering, developing, and delivering best-in-class medicines designed to treat cancer and related conditions. The company leverages its proven scientific expertise and passion for developing novel small molecule drugs designed to target emerging cancer pathways. Infinity’s two most advanced programs are examples of its innovative approach to oncology drug discovery and development. For further information, visit the Company’s web site at www.infi.com.
- 16 years ago
QualityStocks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI)
Tags Rodman & Renshaw
Related Post
-
Calidi Biotherapeutics Inc. (NYSE American: CLDI) Committed to Advancing Cancer Care with Innovative RTNova Platform Research
Cancer statistics underscore the urgency of ongoing cancer research and the need for more effective…
-
ONAR Holding Corp. (ONAR) Is ‘One to Watch’
ONAR is scaling a diversified, AI-driven marketing network addressing multiple high-growth industry verticals. The company…
-
Nutriband Inc. (NASDAQ: NTRB) Leadership Team: Driving Innovation and Shaping the Future of Global Healthcare
Sheridan was recently named as a finalist for the 2025 EY Entrepreneur of the Year…